Rivastigmine tartrate has been used in cholinesterase inhibition assay.
Biochem/physiol Actions
Rivastigmine tartrate is used to treat Alzheimer?s disease. It helps to improve thinking ability. It helps to increase cholinergic function by inhibiting acetylcholinesterase.
Rivastigmine is an orally available, brain penetrant, reversible cholinesterase inhibitor that enhances cognitive function in patients with Alzheimer′s and Parkinson′s diseases. Rivastigmine inhibits both butyrylcholinesterase and acetylcholinesterase.
Features and Benefits
This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Acetylcholine Synthesis and Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
General description
Rivastigmine tartrate is a cholinesterase inhibitor. It is also called as exelon.